Carlos Javier Cerveró
Carlos Javier Cerveró publishes mostly in Hematology, Genetics and Immunology, on topics such as Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research and Chronic Myeloid Leukemia Treatments.
- World rank
- #3,687,589 of 7,710,434 ranked researchers
- Rank in Spain
- #83,690 of 204,306
- Works
- 42
- Citations
- 759
- Citations per work
- 18.1
What does Carlos Javier Cerveró research?
Carlos Javier Cerveró's work is mostly in Medicine (62%), Immunology and Microbiology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2662.2%
- Medicine2662.2%
- Everything else1228.6%
- Life Sciences49.2%
- 1Hematology32% of their works
- 2Genetics14% of their works
- 3Immunology9% of their works
- 4Oncology8% of their works
- 5Public Health, Environmental and Occupational Health4% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
- Acute Myeloid Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Acute Lymphoblastic Leukemia research
- Hematological disorders and diagnostics
- Multiple Myeloma Research and Treatments
Which keywords describe Carlos Javier Cerveró's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Minimal Residual Disease and BCR-ABL.
- FDG PET/CT
- Bone Marrow Biopsy
- Classification
- Acute Lymphoblastic Leukemia
- JAK2 Mutation
- BCR-ABL
- Genomic Aberrations
- Rituximab
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Minimal Residual Disease
- Imatinib
- Myelofibrosis
- Childhood Cancer
- Lymphoma
- Diagnosis Criteria
- International Myeloma Working Group
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Prognostic Factors323 topics
- AML181 topic
- Acute Myeloid Leukemia181 topic
- Rituximab142 topics
- Chronic Lymphocytic Leukemia91 topic
- Genomic Aberrations91 topic
- Minimal Residual Disease92 topics
- BCR-ABL81 topic
- Imatinib81 topic
- JAK2 Mutation61 topic
- Myelofibrosis61 topic
- Acute Lymphoblastic Leukemia51 topic
- Childhood Cancer51 topic
- Classification51 topic
- Lymphoma51 topic
- Bone Marrow Biopsy41 topic
- Diagnosis Criteria41 topic
- FDG PET/CT41 topic
- International Myeloma Working Group41 topic
Where does Carlos Javier Cerveró work?
Carlos Javier Cerveró's main affiliation in the publication record is Hospital Virgen de la Luz, Spain.
How many publications and citations does Carlos Javier Cerveró have?
OpenAlex counts 42 works and 759 citations for Carlos Javier Cerveró, an h-index of 14, ranking #3,687,589 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Carlos Javier Cerveró. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.